Repaglinide · more major-labeled pairs than Octreotide
SPL labels Octreotide + Repaglinide as minor; Octreotide 5 / Repaglinide 17 in that band.
Mechanism on file: Octreotide can change how repaglinide affects your blood sugar, making it harder to keep your levels steady.
FDA SPL severity: Minor
Octreotide + Repaglinide · SPL mechanism field
Octreotide can change how repaglinide affects your blood sugar, making it harder to keep your levels steady.
Minor band excerpt · Octreotide with Repaglinide
Examples: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, nonsteroidal anti-inflammatory agents (NSAIDs), pentoxifylline, pramlintide, propoxyphene, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics Drugs That May Decrease the Blood Glucose Lowering Effect of Repaglinide Intervention: Repaglinide dose increases and increased frequency of glucose monitoring may be required when co-administered.
Octreotide · 5 minor + 14 total pairs
- Bromocriptine minor
- Cyclosporine minor
- Glucagon minor
- Nateglinide minor
Repaglinide · 2 major-labeled pairs (vs Octreotide's 0)
- Albuterol minor
- Clopidogrel minor
- Clozapine minor
- Epinephrine minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.